Citation: | XING Mingquan, WU Weixia, SUN Xiaoxing, WANG Qikai, HAN Hao, GE Hongfeng. A Case of Senile Langerhans Cell Histiocytosis with Soft Tissue Mass as the Main Manifestation[J]. Journal of Rare Diseases, 2023, 2(3): 432-435. DOI: 10.12376/j.issn.2097-0501.2023.03.015 |
Langerhans cell histiocytosis (LCH) is a rare disease characterized by the proliferation of Langerhans cells and the destruction of local tissue. LCH large occurs in children, whilst incidence of the elderly population is extremely low, and there are few related studies. LCH lesions can involve multiple organs and systems, including bone tissue, lymph nodes, skin, liver, and spleen. However, it is rare that multiple soft tissues are implicated for eldly patients with LCH and present with soft tissue mass as the main manifestation. Here is a report on the clinical features, treatment and prognosis of an elderly LCH with multiple soft tissue masses as the main manifestation, in order to provide clinical reference.
[1] |
项泓凯, 陈仕胜, 高宇. 朗格汉斯细胞组织细胞增生症伴血小板增多症1例[J]. 中华皮肤科杂志, 2022, 55(3): 258-259.
|
[2] |
孔丹青, 平娜娜, 金正明, 等. 成人朗格汉斯细胞组织细胞增生症11例临床分析[J]. 上海医学, 2022, 45(2): 110-113. doi: 10.19842/j.cnki.issn.0253-9934.2022.02.010
|
[3] |
曹欣欣. 成人朗格汉斯细胞组织细胞增生症的诊疗[J]. 临床荟萃, 2021, 36(10): 905-909. doi: 10.3969/j.issn.1004-583X.2021.10.008
|
[4] |
马银娟, 王璇, 潘耀柱. 朗格汉斯细胞组织细胞增生症诊治进展[J]. 重庆医学, 2020, 49(3): 489-493, 498. doi: 10.3969/j.issn.1671-8348.2020.03.033
|
[5] |
Llen CE, Ladisch S, Mcclain KL. How I treat Langerhans cell histiocytosis[J]. Blood, 2015, 126 (1): 26-35. doi: 10.1182/blood-2014-12-569301
|
[6] |
Inn DJ, Grimes AB, Lin H, et al. Hydroxyurea: a new old therapy for Langerhans cell histiocytosis[J]. Blood, 2016, 128 (20): 2462-2465. doi: 10.1182/blood-2016-06-721993
|
[7] |
乐颖, 王元阳, 彭全洲, 等. 累及垂体和甲状腺的成人朗格汉斯细胞组织细胞增生症1例[J]. 中华内科杂志, 2022, 61(3): 327-330. doi: 10.3760/cma.j.cn112138-20210601-00388
|
[8] |
黄乐珍, 姜王妹, 邱乾德. 成年人骨骼朗格汉斯细胞组织细胞增生症的影像学表现[J]. 中国医师进修杂志, 2020(1): 61-65. doi: 10.3760/cma.j.issn.1673-4904.2020.01.015
|
[9] |
范枝俏, 潘耀柱, 刘萍, 等. 朗格汉斯细胞组织细胞增生症的研究进展[J]. 中国实验血液学杂志, 2020, 28(1): 354-358. doi: 10.19746/j.cnki.issn1009-2137.2020.01.060
|
[10] |
Roden AC, Yi E S. Pulmonary Langerhans cell histiocy-tosis: an update from the pathologists' perspective[J]. Arch Pathol LabMe, 2016, 140(3): 230-240. doi: 10.5858/arpa.2015-0246-RA
|
[11] |
刘春平, 陈朱城, 顾莹莹. 肺朗格汉斯细胞组织细胞增生症14例临床病理特征[J]. 临床与实验病理学杂志, 2021, 37(7): 848-851. doi: 10.13315/j.cnki.cjcep.2021.07.020
|
[12] |
胡晓玮, 李佳恒, 吴宝玉, 等. 31例朗格汉斯细胞组织细胞增生症的临床病理学特征[J]. 中国校医, 2021, 35(3): 223-225, 234. https://www.cnki.com.cn/Article/CJFDTOTAL-XIYI202103025.htm
|
[13] |
叶承祖, 陆敏, 胡君程. 朗格汉斯细胞组织细胞增生症临床病理分析并文献复习[J]. 诊断病理学杂志, 2022, 29(8): 737-740. doi: 10.3969/j.issn.1007-8096.2022.08.014
|
[14] |
Maarifi G, Czubala MA, Lagisquet J, et al. Langerin(CD207)represents a novel interferon-stimulated gene in Langerhans cells[J]. Cell Mol Immunol, 2019, 17(5): 1-3.
|
[15] |
秦亚萍, 徐新运, 樊祥山, 等. 基于肺活检的原发性肺朗格汉斯细胞组织细胞增生症病理分型及预后分析[J]. 现代肿瘤医学, 2022, 30(1): 61-64. https://www.cnki.com.cn/Article/CJFDTOTAL-SXZL202201013.htm
|
[16] |
Singh J, Rajakulasingam R, Saifuddin A. Langerhans cell histiocytosis of the shoulder girdle, pelvis and extremities: a review of radiographic and MRI features in 85 cases[J]. Skeletal Radiol, 2020, 49(12): 1925-1937. doi: 10.1007/s00256-020-03472-2
|
1. |
唐凤敏,黄滔敏. 眼科玻璃体内注射药物的临床应用研究进展. 中国临床药学杂志. 2025(01): 71-76 .
![]() | |
2. |
张磊,乐偲,刘岩,陈丽萌. 遗传性罕见肾脏病:精准肾脏病学的窗口. 罕见病研究. 2024(01): 1-11 .
![]() | |
3. |
北京大学医学部肾脏病学系专家组. 补体相关性肾病诊断和治疗专家共识. 中华内科杂志. 2024(03): 258-271 .
![]() | |
4. |
邱婧妍,秘红岭. 依库珠单抗治疗阵发性睡眠性血红蛋白尿的研究进展. 医药前沿. 2024(03): 37-39+43 .
![]() | |
5. |
刘爽,刘畅,江丹沁,苏畅,唐一楠. 重症肌无力治疗药物zilucoplan. 中国新药杂志. 2024(24): 2546-2549 .
![]() | |
6. |
林颖,韩露,高圣乔,罗丹,肖智勇,周文霞. 基于转录组数据分析的六味地黄方活性组分LWD-b抗补体作用的发现与验证. 中国药理学与毒理学杂志. 2023(03): 168-177 .
![]() | |
7. |
时念民,李林康,邵祝军,张文宏,吴疆,吕敏,郑佳音,陈直平,刘晓强,张宏,谭颖,刘小荣,赵明辉,罗哲,吕继成,路丽明. 补体相关性肾病人群中脑膜炎球菌疫苗和补体抑制剂联用的专家共识. 慢性病学杂志. 2023(08): 1156-1159 .
![]() |